Live from the NIH registry
Studies recruiting near Worcester right now
Top 25 of 270 recruiting studies, sorted by proximity — each links to its official registry page
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
Obesity
Phase 3
Interventional 600 participants sought
Clinical Res Collaborative — Cumberland, Rhode Island (28.5 mi)
· Sponsor: Novo Nordisk A/S
Zenith® Fenestrated+ Clinical Study
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm
N/A
Interventional 105 participants sought
University of Massachusetts — Worcester, Massachusetts (0.6 mi)
· Sponsor: Cook Research Incorporated
Influences of Long-acting Reversible Contraceptives on Iron Status and Physiological Responses to Extreme Environments in Women
Contraception, Iron Deficiencies
N/A
Observational 33 participants sought
US Army Research Institute of Environmental Medicine — Natick, Massachusetts (23.5 mi)
· Sponsor: United States Army Research Institute of Environmental Medicine
Promoting Improved Functioning Among People Experiencing Stressful Situations
Acute Stress Reaction
N/A
Interventional 450 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of North Carolina, Chapel Hill
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Migraine
Phase 3
Interventional 200 participants sought
New England Regional Headache Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: Pfizer
Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application
Epilepsy, Refractory Epilepsy
N/A
Interventional 24 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Dartmouth-Hitchcock Medical Center
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
Systemic Sclerosis
Phase 3
Interventional 92 participants sought
Local Institution - 0084 — Worcester, Massachusetts (0.6 mi)
· Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Asthma Link Effectiveness Trial
Childhood Asthma
N/A
Interventional 350 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
Validation of Chlamydia Diagnostic Codes in TriNetX US EHR Data
Chlamydial Infections
N/A
Observational 533,000 participants sought
University of Massachusetts Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Sanofi
Pelvic Vein Quantitative Flow Characterization Using 2D and 4D Flow MRI
May-Thurner Syndrome, Iliac Venous Compression
N/A
Interventional 15 participants sought
University of Massachusetts — Worcester, Massachusetts (0.6 mi)
· Sponsor: Ningcheng Peter Li
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
Venous Thromboses, Venous Disease
N/A
Interventional 165 participants sought
Vascular Care Group — Wellesley, Massachusetts (26.4 mi)
· Sponsor: W.L.Gore & Associates
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
UMass Memorial Medical Center - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 425 participants sought
University of Massachusetts Memorial Medical Center — North Worcester, Massachusetts (3.2 mi)
· Sponsor: Hoffmann-La Roche
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus, Lupus Nephritis
Phase 1, Phase 2
Interventional 28 participants sought
UMass Memorial Hospital — Worcester, Massachusetts (0.6 mi)
· Sponsor: Cabaletta Bio
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 2
Interventional 80 participants sought
UMass Memorial Medical Center - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: Children's Oncology Group
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Type B Aortic Dissection
N/A
Interventional 1,100 participants sought
University of Massachusetts Memorial — Worcester, Massachusetts (0.6 mi)
· Sponsor: Duke University
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional — Milford, Massachusetts (17.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Ovarian Neoplasms, Fallopian Tube Neoplasms
Phase 3
Interventional 1,630 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Eli Lilly and Company
Lupus Landmark Study: A Prospective Registry and Biorepository
Systemic Lupus Erythematosus (SLE), Lupus Nephritis
N/A
Observational 3,500 participants sought
University of Massachusetts Memorial Health — Worcester, Massachusetts (0.6 mi)
· Sponsor: Lupus Research Alliance
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Major Depressive Disorder (MDD), Depressive Disorder, Treatment-Resistant
Phase 2
Interventional 153 participants sought
Vitalix Clinical, Inc. — Worcester, Massachusetts (0.6 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Reliant Medical Group Inc — Worcester, Massachusetts (0.6 mi)
· Sponsor: Amgen
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial Meningioma, Recurrent Meningioma
Phase 2
Interventional 124 participants sought
UMass Memorial Medical Center - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
Acute Treatment of Migraine
Phase 4
Interventional 400 participants sought
New England Regional Headache Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: Pfizer
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
Breast Cancer
N/A
Interventional 2,032 participants sought
Boston Breast Diagnostic Center — Wellesley Hills, Massachusetts (27.2 mi)
· Sponsor: American College of Radiology
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
Kuchnir Dermatology & Dermatologic Surgery- Site Number : 8400096 — Marlborough, Massachusetts (14.1 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company